Pfizer Forecasts $15 Billion In Revenue From COVID Vaccine In 2021

Meg Tirrell breaks down Pfizer's fourth-quarter earnings results and adjusted full-year guidance.

(Video length 00:01:13)

CNBC's Meg Tirrell breaks down Pfizer's fourth-quarter earnings results and adjusted full-year guidance.

STOCKS IN THIS ARTICLE

Comments